T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
NCR Voyix
VYX
$1.17B
| $26.3M | ﹤0.01% |
1,511,033
-15,366
| -1% | -$274K |
|
|
SJIU
1127
DELISTED
South Jersey Industries, Inc.
SJIU
| $26.3M | ﹤0.01% |
463,184
+2,652
| +0.6% | +$146K |
|
|
WRK
1128
DELISTED
WestRock Company
WRK
| $26.3M | ﹤0.01% |
492,342
-381,529
| -44% | -$21.4M |
|
1129
Phibro Animal Health
PAHC
$1.38B
| $26.1M | ﹤0.01% |
607,892
+36,514
| +6% | +$1.73M |
|
1130
Ameren
AEE
$30.2B
| $26M | ﹤0.01% |
411,620
-3,700
| -0.9% | -$233K |
|
1131
HF Sinclair
DINO
$16.3B
| $25.9M | ﹤0.01% |
370,867
+81,419
| +28% | +$5.75M |
|
1132
Lincoln National
LNC
$8.67B
| $25.9M | ﹤0.01% |
382,789
-4,700
| -1% | -$310K |
|
|
CATM
1133
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $25.9M | ﹤0.01% |
817,375
+75,822
| +10% | +$2.33M |
|
1134
Celanese
CE
$4.86B
| $25.9M | ﹤0.01% |
226,803
+3,431
| +2% | +$393K |
|
1135
CBRE Group
CBRE
$44B
| $25.8M | ﹤0.01% |
585,954
+9,770
| +2% | +$466K |
|
1136
Hormel Foods
HRL
$13.4B
| $25.8M | ﹤0.01% |
655,700
-102,366
| -14% | -$3.92M |
|
1137
Sportsman's Warehouse
SPWH
$46.8M
| $25.7M | ﹤0.01% |
4,385,057
+2,108,823
| +93% | +$11.5M |
|
1138
Galicia Financial Group
GGAL
$7.23B
| $25.6M | ﹤0.01% |
1,008,366
+189,620
| +23% | +$5.74M |
|
|
PRNB
1139
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $25.3M | ﹤0.01% |
+867,059
| New | +$24.5M |
|
1140
Principal Financial Group
PFG
$24.6B
| $25.3M | ﹤0.01% |
432,214
-37,420
| -8% | -$2.09M |
|
1141
Cibus
CBUS
$145M
| $25.3M | ﹤0.01% |
33,122
-94
| -0.3% | -$80.7K |
|
1142
Natera
NTRA
$44.8B
| $25.3M | ﹤0.01% |
+1,055,462
| New | +$25.5M |
|
1143
Genuine Parts
GPC
$18.7B
| $25.3M | ﹤0.01% |
254,032
+5,800
| +2% | +$569K |
|
|
WDR
1144
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $25M | ﹤0.01% |
1,178,544
+14,411
| +1% | +$290K |
|
1145
Robert Half
RHI
$4.48B
| $24.9M | ﹤0.01% |
354,368
-1,631
| -0.5% | -$119K |
|
1146
Targa Resources
TRGP
$57.2B
| $24.8M | ﹤0.01% |
441,277
+333,757
| +310% | +$17.8M |
|
1147
D.R. Horton
DHI
$41.9B
| $24.8M | ﹤0.01% |
588,975
-33
| -0% | -$1.43K |
|
1148
Waters Corp
WAT
$40.6B
| $24.8M | ﹤0.01% |
127,455
-7,811
| -6% | -$1.51M |
|
1149
Quest Diagnostics
DGX
$26.1B
| $24.8M | ﹤0.01% |
229,876
+3,574
| +2% | +$392K |
|
1150
Saga Communications
SGA
$61.8M
| $24.8M | ﹤0.01% |
685,245
-12,638
| -2% | -$469K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.